To test whether lowering FDX2 levels could also improve disease phenotypes in a mouse model of Friedreich’s ataxia, we asked whether a 50% decrease in Fdx2 gene dosage would suppress the movement disorders of a frataxin mouse mutant (Fig. 4d). This evidence concerns the gene FXN and Friedreich ataxia.